Asked by Amora
Essential Questions • What fundamental characteristics do all cancers have in common? • In what ways are diagnostic imaging technologies used to diagnose and treat disorders? • What do DNA microarrays measure? • How is DNA microarray technology used to determine the differences in gene expression between different tissue samples? • How are the similarities of gene expression patterns between different individuals calculated?
All Answers 1
Answered by
GPT-5 mini
AI
Here are concise answers to each question.
1) What fundamental characteristics do all cancers have in common?
- Uncontrolled cell proliferation (sustained proliferative signaling).
- Evasion of growth suppressors (loss of tumor suppressor function).
- Resistance to cell death (apoptosis evasion).
- Replicative immortality (telomerase activation or other mechanisms).
- Induction of angiogenesis (new blood vessel growth to feed tumor).
- Invasion and metastasis (ability to spread to other tissues).
- Genome instability and mutation (increased mutation rate fueling evolution).
- Tumor-promoting inflammation (microenvironment that supports cancer).
- Reprogramming of energy metabolism (e.g., increased glycolysis).
- Avoidance of immune destruction.
(These reflect the “hallmarks of cancer” framework; not every tumor shows all hallmarks equally, but most cancers acquire many of them.)
2) In what ways are diagnostic imaging technologies used to diagnose and treat disorders?
- Detection and diagnosis: identify abnormal structures (tumors, fractures, lesions) and characterize size, shape, density, enhancement.
- Staging and extent: determine local invasion and distant metastases (essential for cancer staging).
- Functional and molecular assessment: PET, SPECT, functional MRI reveal metabolic activity, perfusion, receptor expression, or functional changes.
- Treatment planning: image-based planning for surgery and radiation therapy (CT/MRI used to delineate targets).
- Image-guided interventions: biopsies, catheter placement, ablation, angioplasty, and minimally invasive surgery guided by real-time ultrasound, CT, or fluoroscopy.
- Monitoring response: follow-up imaging to assess treatment effect, detect recurrence, or complication.
- Therapeutic imaging (theranostics): radiopharmaceuticals used both to image and to deliver targeted radiation (e.g., radio-labeled peptides).
- Intraoperative and bedside uses: ultrasound, fluoroscopy, and portable CT for real-time decisions.
Common modalities: X-ray, CT, MRI, ultrasound, PET, SPECT, nuclear medicine, and hybrid modalities (PET/CT, PET/MRI).
3) What do DNA microarrays measure?
- DNA microarrays (gene expression arrays) primarily measure relative abundance of mRNA transcripts for thousands of genes simultaneously; this gives a snapshot of gene expression levels in a sample.
- Variants of microarrays can also detect SNPs/genotypes, copy-number variation, or methylation, but classic expression arrays measure RNA-derived signals.
4) How is DNA microarray technology used to determine the differences in gene expression between different tissue samples?
Typical workflow:
- Sample collection: obtain tissue/cells from the conditions to compare (e.g., tumor vs normal).
- RNA extraction: isolate total RNA and often enrich for mRNA.
- Labeling/cDNA synthesis: convert RNA to labeled cDNA or cRNA (fluorescent labels or biotin).
- Hybridization: apply labeled targets to the array where probes for thousands of genes are fixed.
- Washing and scanning: remove unbound material and scan the array to quantify probe signals (intensity per probe).
- Preprocessing: background correction and normalization (e.g., quantile normalization, RMA) to make arrays comparable.
- Expression value calculation: convert probe intensities into gene-level expression values (often log2-transformed).
- Differential expression analysis: compute fold-changes (e.g., log2 fold-change) between sample groups and apply statistical tests (t-test, linear models) with multiple-testing correction (FDR) to identify significantly differentially expressed genes.
- Interpretation and visualization: heatmaps, volcano plots, pathway and enrichment analysis to understand biological meaning.
5) How are the similarities of gene expression patterns between different individuals calculated?
- Represent each individual/sample by a vector of gene expression values (one value per gene). Then quantify similarity or distance between vectors using metrics such as:
- Pearson correlation coefficient: assesses linear relationship between expression profiles (values between -1 and 1). High positive r means profiles are similar in pattern.
- Spearman rank correlation: compares ranked expression patterns (robust to nonlinearity and outliers).
- Euclidean distance: sqrt(sum (xi – yi)^2) — measures absolute difference in expression levels.
- Other distance metrics: Manhattan distance, cosine similarity, Canberra, etc.
- These pairwise similarities/distances are used for:
- Clustering samples (hierarchical clustering, k-means) to group similar individuals.
- Dimensionality reduction (PCA, MDS, t-SNE, UMAP) to visualize sample relationships.
- Network analysis or sample classification (e.g., nearest neighbor classifiers).
- Practical considerations: always normalize data first, often filter low-variance genes (noise), and use multiple metrics to confirm robustness.
If you want, I can:
- Show a small numeric example of computing Pearson correlation or Euclidean distance between two expression profiles.
- Walk through an example microarray analysis pipeline using specific tools (e.g., R/Bioconductor commands).
1) What fundamental characteristics do all cancers have in common?
- Uncontrolled cell proliferation (sustained proliferative signaling).
- Evasion of growth suppressors (loss of tumor suppressor function).
- Resistance to cell death (apoptosis evasion).
- Replicative immortality (telomerase activation or other mechanisms).
- Induction of angiogenesis (new blood vessel growth to feed tumor).
- Invasion and metastasis (ability to spread to other tissues).
- Genome instability and mutation (increased mutation rate fueling evolution).
- Tumor-promoting inflammation (microenvironment that supports cancer).
- Reprogramming of energy metabolism (e.g., increased glycolysis).
- Avoidance of immune destruction.
(These reflect the “hallmarks of cancer” framework; not every tumor shows all hallmarks equally, but most cancers acquire many of them.)
2) In what ways are diagnostic imaging technologies used to diagnose and treat disorders?
- Detection and diagnosis: identify abnormal structures (tumors, fractures, lesions) and characterize size, shape, density, enhancement.
- Staging and extent: determine local invasion and distant metastases (essential for cancer staging).
- Functional and molecular assessment: PET, SPECT, functional MRI reveal metabolic activity, perfusion, receptor expression, or functional changes.
- Treatment planning: image-based planning for surgery and radiation therapy (CT/MRI used to delineate targets).
- Image-guided interventions: biopsies, catheter placement, ablation, angioplasty, and minimally invasive surgery guided by real-time ultrasound, CT, or fluoroscopy.
- Monitoring response: follow-up imaging to assess treatment effect, detect recurrence, or complication.
- Therapeutic imaging (theranostics): radiopharmaceuticals used both to image and to deliver targeted radiation (e.g., radio-labeled peptides).
- Intraoperative and bedside uses: ultrasound, fluoroscopy, and portable CT for real-time decisions.
Common modalities: X-ray, CT, MRI, ultrasound, PET, SPECT, nuclear medicine, and hybrid modalities (PET/CT, PET/MRI).
3) What do DNA microarrays measure?
- DNA microarrays (gene expression arrays) primarily measure relative abundance of mRNA transcripts for thousands of genes simultaneously; this gives a snapshot of gene expression levels in a sample.
- Variants of microarrays can also detect SNPs/genotypes, copy-number variation, or methylation, but classic expression arrays measure RNA-derived signals.
4) How is DNA microarray technology used to determine the differences in gene expression between different tissue samples?
Typical workflow:
- Sample collection: obtain tissue/cells from the conditions to compare (e.g., tumor vs normal).
- RNA extraction: isolate total RNA and often enrich for mRNA.
- Labeling/cDNA synthesis: convert RNA to labeled cDNA or cRNA (fluorescent labels or biotin).
- Hybridization: apply labeled targets to the array where probes for thousands of genes are fixed.
- Washing and scanning: remove unbound material and scan the array to quantify probe signals (intensity per probe).
- Preprocessing: background correction and normalization (e.g., quantile normalization, RMA) to make arrays comparable.
- Expression value calculation: convert probe intensities into gene-level expression values (often log2-transformed).
- Differential expression analysis: compute fold-changes (e.g., log2 fold-change) between sample groups and apply statistical tests (t-test, linear models) with multiple-testing correction (FDR) to identify significantly differentially expressed genes.
- Interpretation and visualization: heatmaps, volcano plots, pathway and enrichment analysis to understand biological meaning.
5) How are the similarities of gene expression patterns between different individuals calculated?
- Represent each individual/sample by a vector of gene expression values (one value per gene). Then quantify similarity or distance between vectors using metrics such as:
- Pearson correlation coefficient: assesses linear relationship between expression profiles (values between -1 and 1). High positive r means profiles are similar in pattern.
- Spearman rank correlation: compares ranked expression patterns (robust to nonlinearity and outliers).
- Euclidean distance: sqrt(sum (xi – yi)^2) — measures absolute difference in expression levels.
- Other distance metrics: Manhattan distance, cosine similarity, Canberra, etc.
- These pairwise similarities/distances are used for:
- Clustering samples (hierarchical clustering, k-means) to group similar individuals.
- Dimensionality reduction (PCA, MDS, t-SNE, UMAP) to visualize sample relationships.
- Network analysis or sample classification (e.g., nearest neighbor classifiers).
- Practical considerations: always normalize data first, often filter low-variance genes (noise), and use multiple metrics to confirm robustness.
If you want, I can:
- Show a small numeric example of computing Pearson correlation or Euclidean distance between two expression profiles.
- Walk through an example microarray analysis pipeline using specific tools (e.g., R/Bioconductor commands).
Submit Your Answer
We prioritize human answers over AI answers.
If you are human, and you can answer this question, please submit your answer.